Skip to main content
TipRanks
Go Ultimate75% OFF

Paul Daruwala Insider Profile

4 Followers

Paul Daruwala, former COO at Cidara Therapeutics, holds 221.10K shares in Cidara Therapeutics (Ticker: CDTX). Most recently, Paul Daruwala Sold 16,199 shares of Cidara Therapeutics on Sep 13, 2022 for an estimated value of $11.02K.

Paul Daruwala's Trading History

CDTX
Cidara Therapeutics
Sep 13, 2022―Informative Sell11.02K$48.95M
CDTX
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Sep 13, 2022Informative Sell$11.02K16,199$0.68-56.80%
Apr 04, 2022Uninformative Buy$0.0050,000$0.00―
Jan 07, 2022Uninformative Buy$5.72K4,767$1.20―
Oct 04, 2021Uninformative Buy$0.00132,000$0.00―
Apr 05, 2021Informative Sell$7.49K3,461$2.16+65.10%

You May Also Like

Paul Daruwala insider profile FAQ

What is the percentage of profitable transactions made by Paul Daruwala?
The percentage of profitable transactions made by Paul Daruwala is 40%.
What is the average return per transaction made by Paul Daruwala?
The average return per transaction made by Paul Daruwala is -4.10%.
What stocks does Paul Daruwala hold?
Paul Daruwala holds: CDTX stocks.
What was Paul Daruwala’s latest transaction?
Paul Daruwala’s latest transaction was an Informative Sell of $11.02K.
What was Paul Daruwala's most profitable transaction?
Paul Daruwala’s most profitable transaction was an Informative Sell of CDTX stock on April 5, 2021. The return on the trade was 65.10%.
What is Paul Daruwala's role in Cidara Therapeutics?
Paul Daruwala's role in Cidara Therapeutics is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.